Related Experiment Videos

Murine peritoneal macrophages activated by the mycobacterial 65-kilodalton heat shock protein express enhanced

W E Peetermans1, J A Langermans, M E van der Hulst

  • 1Department of Infectious Diseases, University Hospital, Leiden, The Netherlands.

Insights

The 65-kDa heat shock protein (Hsp 65) from Mycobacterium can activate mouse peritoneal macrophages, enhancing their ability to fight infections like Toxoplasma gondii and Listeria monocytogenes when combined with an adjuvant. However, this in vitro activation did not translate to improved pathogen clearance in vivo.

Area of Science:

  • Immunology
  • Microbiology
  • Cell Biology

Background:

  • Mycobacterium bovis bacillus Calmette-Guérin (BCG) infection enhances peritoneal macrophage antimicrobial activity.
  • The 65-kDa heat shock protein (Hsp 65) is an immunodominant antigen of Mycobacterium species.

Purpose of the Study:

  • To investigate if Hsp 65 injection activates mouse peritoneal macrophages.
  • To determine the role of adjuvants in eliciting an immune response to Hsp 65.

Main Methods:

  • Mice were injected with Hsp 65 alone or with the adjuvant dimethyl dioctadecylammonium bromide (DDA).
  • Peritoneal macrophages were isolated and assessed for respiratory burst (H2O2 release), inhibition of Toxoplasma gondii proliferation, and killing of Listeria monocytogenes.
  • In vivo bacterial growth was measured in the liver and spleen.

Main Results:

  • Hsp 65 with DDA activated peritoneal macrophages, increasing H2O2 production and enhancing inhibition of T. gondii and killing of L. monocytogenes in vitro.
  • Hsp 65 alone did not induce macrophage activation, indicating adjuvant requirement.
  • Macrophage phagocytosis rate was unaffected.
  • No significant difference in L. monocytogenes growth was observed in the liver and spleen between Hsp 65-treated and control mice.

Conclusions:

  • Hsp 65, when formulated with an adjuvant like DDA, can induce in vitro activation of peritoneal macrophages with enhanced microbicidal activity.
  • Despite in vitro findings, Hsp 65 treatment did not confer protection against L. monocytogenes infection in vivo.

Related Concept Videos